JP2007503841A5 - - Google Patents

Download PDF

Info

Publication number
JP2007503841A5
JP2007503841A5 JP2006526218A JP2006526218A JP2007503841A5 JP 2007503841 A5 JP2007503841 A5 JP 2007503841A5 JP 2006526218 A JP2006526218 A JP 2006526218A JP 2006526218 A JP2006526218 A JP 2006526218A JP 2007503841 A5 JP2007503841 A5 JP 2007503841A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006526218A
Other languages
Japanese (ja)
Other versions
JP2007503841A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/028970 external-priority patent/WO2005023987A2/en
Publication of JP2007503841A publication Critical patent/JP2007503841A/ja
Publication of JP2007503841A5 publication Critical patent/JP2007503841A5/ja
Pending legal-status Critical Current

Links

JP2006526218A 2003-09-03 2004-09-02 薬剤作用を決定するための細胞ベースのアッセイ法 Pending JP2007503841A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50018003P 2003-09-03 2003-09-03
PCT/US2004/028970 WO2005023987A2 (en) 2003-09-03 2004-09-02 Cell-based assays for determining drug action

Publications (2)

Publication Number Publication Date
JP2007503841A JP2007503841A (ja) 2007-03-01
JP2007503841A5 true JP2007503841A5 (enExample) 2007-12-06

Family

ID=34272923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006526218A Pending JP2007503841A (ja) 2003-09-03 2004-09-02 薬剤作用を決定するための細胞ベースのアッセイ法

Country Status (6)

Country Link
US (1) US20070072246A1 (enExample)
EP (1) EP1668361A4 (enExample)
JP (1) JP2007503841A (enExample)
AU (1) AU2004271183A1 (enExample)
CA (1) CA2576406A1 (enExample)
WO (1) WO2005023987A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094992A2 (en) * 2003-04-23 2004-11-04 Bioseek, Inc. Methods for analysis of biological dataset profiles
US8019551B2 (en) 2004-02-27 2011-09-13 Bioseek Llc Biological dataset profiling of asthma and atopy
US20060141508A1 (en) * 2004-11-30 2006-06-29 Michelle Palmer Cellular signaling pathway based assays, reagents and kits
US9734282B2 (en) 2005-03-28 2017-08-15 Discoverx Corporation Biological dataset profiling of cardiovascular disease and cardiovascular inflammation
US20090170091A1 (en) * 2006-01-17 2009-07-02 Kenneth Giuliano Method For Predicting Biological Systems Responses
CN101484806A (zh) 2006-05-17 2009-07-15 协乐民公司 一种对组织进行自动分析的方法
WO2007139895A2 (en) * 2006-05-24 2007-12-06 Cellumen, Inc. Method for modeling a disease
EP2023874A4 (en) 2006-06-02 2009-07-08 Bioseek Inc METHOD FOR IDENTIFYING ACTIVE SUBSTANCES AND THEIR USE FOR THE PREVENTION OF RESTENOSIS
EP2095119A2 (en) * 2006-11-10 2009-09-02 Cellumen, Inc. Protein-protein interaction biosensors and methods of use thereof
EP2135078B1 (en) * 2007-03-09 2013-08-21 DiscoveRx Corporation Methods for identifying agents and their use for the prevention or stabilization of fibrosis
WO2008121896A2 (en) 2007-03-30 2008-10-09 Bioseek, Inc. Methods for classification of toxic agents and counteragents
US8536135B2 (en) * 2008-03-19 2013-09-17 Ontherix, Inc. Adaptive biochemical signatures
CA2718969A1 (en) * 2008-03-19 2009-09-24 Ontherix, Inc. Adaptive biochemical signatures
ES2739623T3 (es) 2011-03-17 2020-02-03 Cernostics Inc Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos
US20170363614A1 (en) * 2014-12-22 2017-12-21 Enumeral Biomedical Holdings, Inc. Methods For Screening Therapeutic Compounds
WO2016168565A1 (en) * 2015-04-16 2016-10-20 President And Fellows Of Harvard College Methods for treatment of chronic obstructive pulmonary disease and/or therapy monitoring
CN112466403B (zh) * 2020-12-31 2022-06-14 广州基迪奥生物科技有限公司 一种细胞通讯分析方法及系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7266458B2 (en) * 2000-03-06 2007-09-04 Bioseek, Inc. BioMAP analysis
JP4798921B2 (ja) * 2000-03-06 2011-10-19 バイオシーク インコーポレーティッド 機能相同性スクリーニング
US6763307B2 (en) * 2000-03-06 2004-07-13 Bioseek, Inc. Patient classification
WO2003068908A2 (en) * 2001-07-10 2003-08-21 Gene Logic, Inc. Cardiotoxin molecular toxicology modeling
US7623969B2 (en) * 2002-01-31 2009-11-24 The Institute For Systems Biology Gene discovery for the system assignment of gene function
US20050095592A1 (en) * 2002-02-13 2005-05-05 Jazaeri Amir A. Identification of ovarian cancer tumor markers and therapeutic targets
US20070087344A1 (en) * 2003-04-23 2007-04-19 Bioseek, Inc. Methods for characterizing signaling pathways and compounds that interact therewith
WO2004094992A2 (en) * 2003-04-23 2004-11-04 Bioseek, Inc. Methods for analysis of biological dataset profiles

Similar Documents

Publication Publication Date Title
BE2024C508I2 (enExample)
BE2023C542I2 (enExample)
BE2020C513I2 (enExample)
BE2020C517I2 (enExample)
BE2019C540I2 (enExample)
BE2019C523I2 (enExample)
BE2019C548I2 (enExample)
BE2019C506I2 (enExample)
BE2020C525I2 (enExample)
BE2017C063I2 (enExample)
BE2017C027I2 (enExample)
BE2016C067I2 (enExample)
BE2015C041I2 (enExample)
BE2015C014I2 (enExample)
BE2015C015I2 (enExample)
BE2014C064I2 (enExample)
BE2014C063I2 (enExample)
BE2014C010I2 (enExample)
BE2013C071I2 (enExample)
BE2013C021I2 (enExample)
BE2015C066I2 (enExample)
BE2015C065I2 (enExample)
BE2019C535I2 (enExample)
BE2015C033I2 (enExample)
BE2015C012I2 (enExample)